All News

Your daily dose of the clinical news you may have missed.

An overview of safe treatment options for migraine attacks that may occur during pregnancy for primary care clinicians, here.

The 100 mg dose prefilled syringes are in particularly short supply and while the shortage of the 50 mg dose is not as severe, supply will be limited this season.

Experts delve into the complexities of cancer screening, from identifying high-risk individuals to counseling patients about the nuances of screening tests, all while aiming for early detection and improved outcomes.

Experts discuss the transition from evidence-based medicine to precision medicine in the context of cancer screening, emphasizing the urgency of implementing multi-cancer screening for broad positive outcomes.

Get a topline look at 8 of the many studies premiered at IDWeek that have outcomes of interest to primary care clinicians.

Findings from phase 3 ACCORD clinical trial demonstrated rapid and sustained clinical response in patients with Alzheimer disease agitation with no new safety signals reported.

Tirzepatide could help individuals who lose weight with lifestyle change to maintain and augment that loss, a well known challenge among persons with obesity.

Your daily dose of the clinical news you may have missed.

Your daily dose of the clinical news you may have missed.

Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.

The flexibility to self administer a flu vaccine or to administer to another in a non-clinical setting could greatly expand both access and vaccine uptake.

Experts highlight considerations for patients with chronic kidney disease and other comorbid conditions, particularly diabetes, in terms of screening and preventative care.

Experts discuss key challenges in testing and diagnosing a patient with chronic kidney disease, especially for those who are asymptomatic. In addition, they highlight new screening approaches to accurately identify these patients.

The investigational combination vaccine against influenza and SARS-CoV-2 proved both safe and effective in recent results from a phase 1/2 trial, said Moderna.

Your daily dose of the clinical news you may have missed.

The Pfizer product is the first vaccine indicated to prevent the 5 most common serogroups causing meningococcal disease in adolescents and young adults.

The 2 highest doses of tirzepatide were ranked most likely to be effective for weight management in persons without diabetes, followed by semaglutide 2.4 mg.